Pharmaceuticals Companies By Roa

Return On Asset
ROAEfficiencyMarket RiskExp Return
1SIGA SIGA Technologies
0.38
 0.08 
 6.36 
 0.49 
2NVO Novo Nordisk AS
0.23
 0.00 
 2.40 
(0.01)
3ZTS Zoetis Inc
0.14
 0.13 
 1.46 
 0.19 
4HRMY Harmony Biosciences Holdings
0.14
 0.18 
 2.43 
 0.44 
5LLY Eli Lilly and
0.14
 0.05 
 2.36 
 0.12 
6CORT Corcept Therapeutics Incorporated
0.13
 0.18 
 2.14 
 0.39 
7MRK Merck Company
0.11
(0.08)
 1.79 
(0.15)
8COLL Collegium Pharmaceutical
0.11
 0.10 
 2.47 
 0.26 
9RDY Dr Reddys Laboratories
0.11
 0.15 
 1.38 
 0.21 
10AMPH Amphastar P
0.1
 0.10 
 2.67 
 0.26 
11GSK GlaxoSmithKline PLC ADR
0.0956
 0.09 
 1.33 
 0.12 
12NVS Novartis AG ADR
0.0886
 0.15 
 1.08 
 0.17 
13INVA Innoviva
0.0852
 0.27 
 1.18 
 0.32 
14JNJ Johnson Johnson
0.081
 0.20 
 1.09 
 0.22 
15AZN AstraZeneca PLC ADR
0.0768
 0.01 
 1.18 
 0.01 
16OGN Organon Co
0.0727
 0.02 
 2.34 
 0.04 
17PBH Prestige Brand Holdings
0.0619
 0.14 
 1.47 
 0.20 
18AMRX Amneal Pharmaceuticals, Class
0.0609
 0.16 
 2.51 
 0.40 
19BMY Bristol Myers Squibb
0.06
 0.15 
 2.15 
 0.31 
20TEVA Teva Pharma Industries
0.0516
 0.05 
 2.10 
 0.10 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time. Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.